StockNews.com upgraded shares of Baxter International (NYSE:BAX – Free Report) from a hold rating to a buy rating in a report published on Friday morning. A number of other equities analysts have also recently commented on the company. Citigroup decreased their target price on Baxter International from $45.00 to $41.00 in a report on Monday, […]
StockNews.com upgraded shares of Baxter International (NYSE:BAX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other research analysts also recently issued research reports about the company. Morgan Stanley reduced their price target on Baxter International from $45.00 to $39.00 and set an equal weight rating for […]
StockNews.com downgraded shares of Baxter International (NYSE:BAX – Free Report) from a buy rating to a hold rating in a research report released on Tuesday morning. Several other research analysts have also weighed in on the company. Morgan Stanley cut their target price on Baxter International from $45.00 to $39.00 and set an equal weight […]
Baxter International Inc. (NYSE:BAX – Get Free Report) declared a quarterly dividend on Tuesday, November 14th, RTT News reports. Stockholders of record on Friday, December 1st will be paid a dividend of 0.29 per share by the medical instruments supplier on Tuesday, January 2nd. This represents a $1.16 annualized dividend and a dividend yield of […]
Carmel Capital Partners LLC trimmed its stake in Baxter International Inc. (NYSE:BAX – Free Report) by 3.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,265 shares of the medical instruments supplier’s stock after selling 610 shares during the quarter. Carmel Capital Partners […]